Reports of side-effects from Bayer’s Xarelto grow -Spiegel

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Xarelto is used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. There is limited information on how effective it is compared to warfarin (coumadin). The FDA approved it’s use in the US in November 2011.

A German magazine, Der Spiegel,  published an article about the extrordinary amount of reported side effects in Germany from the drug Xarelto. They state:

  • In 2013, for 8 months, 968 cases of (suspected) side effects, including 72 deaths.
  • In 2012, for the full year, 750 cases of side-effects, including 58 cases of death.

Bayer projects $2b in sales for Xarelto. Via Reuters

– MedShadow Staff

Did you find this article helpful?

Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement